Group Telehealth Behavioral Cough Suppression Therapy
Part of paid clinical trials in Missoula, Montana.
- Sponsor
- University of Montana
- Study ID
- NCT06706765
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Refractory Chronic Cough
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Behavioral Treatment — BEHAVIORALBehavioral cough suppression therapy delivered in a group setting via telehealth.
Study Details
The purpose of this study is to investigate the effectiveness of behavioral cough suppression therapy (BCST) in managing refractory chronic cough (RCC) within a group telehealth setting. RCC is a cough that has lasted at least 8 weeks and has not resolved with standard medical treatment. BCST is a research-based treatment provided by specialty-trained speech-language pathologists (SLPs) for patients with RCC. Although the treatment works very well for a large proportion of patients in a standard one-on-one format, there are a limited number of SLPs available to provide this treatment and patients living in rural areas do not typically have access to an SLP trained in BCST. If BCST can effectively be delivered in a group telehealth model, it would significantly improve accessibility to the treatment.
Key Dates
- Start date
- Mar 22, 2024
- Status verified
- Aug 2024
- Primary completion
- Jan 31, 2025
- Completion
- Jan 31, 2025
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Group Telehealth Behavioral Cough Suppression Therapy
Primary Outcome Measure
Leicester Cough Questionnaire [ Time Frame: Baseline, one-week post-treatment, and one-month post-treatment ]
Central Contacts
- Jane E Reynolds, PhD406-243-2138
- Laurie J Slovarp, PhD406-243-2107
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Montana | Missoula | Montana | 59812 | Laurie J Slovarp, PhD Jane E Reynolds, PhD |
Find similar trials in Missoula, MT
Related Studies
- Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic CoughPHASE2 · Not Yet Recruiting · University of Montana · Aurora, Colorado
- Efficacy of Two Doses of Duloxetine and Amitriptyline in Subjects With Refractory Chronic CoughPHASE2 · Recruiting · Mayo Clinic · Rochester, Minnesota
- Cough Management Wellness App for Refractory or Unexplained Chronic CoughRecruiting · Hyfe Inc · Wilmington, Delaware